Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-06

Clinical Trial Update: Effect of Cequa™ in Subjects With Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating Cequa in subjects with dry eye disease; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cequa (cyclosporine ophthalmic solution)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Dry Eye Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-02-06